Clinical Trials
23
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (18 trials with phase data)• Click on a phase to view related trials
Pembrolizumab and Pemetrexed for Progressive Chordoma
- Conditions
- ChordomasChordoma
- Interventions
- First Posted Date
- 2025-01-27
- Last Posted Date
- 2025-01-27
- Lead Sponsor
- Saint John's Cancer Institute
- Target Recruit Count
- 21
- Registration Number
- NCT06794645
- Locations
- 🇺🇸
Providence Saint John's Health Center, Santa Monica, California, United States
Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation.
- Conditions
- IORT-Intra-Operative Radiation Therapy
- First Posted Date
- 2022-03-21
- Last Posted Date
- 2023-04-11
- Lead Sponsor
- Saint John's Cancer Institute
- Target Recruit Count
- 30
- Registration Number
- NCT05289466
- Locations
- 🇺🇸
Providence Saint John's Hospital, Santa Monica, California, United States
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
- Conditions
- Early-stage Breast CancerBreast Carcinoma in SituBreast Neoplasms
- First Posted Date
- 2020-10-26
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Saint John's Cancer Institute
- Target Recruit Count
- 1000
- Registration Number
- NCT04603209
- Locations
- 🇺🇸
John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, California, United States
The PREVENTION Trial: Precision Recommendations to Optimize Neurocognition
- Conditions
- Alzheimer DiseaseMild Cognitive Impairment
- First Posted Date
- 2019-09-09
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Saint John's Cancer Institute
- Target Recruit Count
- 97
- Registration Number
- NCT04082611
- Locations
- 🇺🇸
Pacific Brain Health Center, Santa Monica, California, United States
Pemetrexed for the Treatment of Chordoma
- First Posted Date
- 2019-05-17
- Last Posted Date
- 2023-03-07
- Lead Sponsor
- Saint John's Cancer Institute
- Target Recruit Count
- 15
- Registration Number
- NCT03955042
- Locations
- 🇺🇸
John Wayne Cancer Institute, Santa Monica, California, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- Next